1,720,976 research outputs found
How can we foster digital technology adoption in the Pharmaceutical Supply Chain? The role of actors’ supporting initiatives.
No full textDigital technologies (DT) hold the potential to transform the Pharmaceutical Supply Chain (PSC), offering several benefits in patient safety, regulatory compliance, and operational efficiency. These include real-time tracking, enhanced traceability, remote medication monitoring, and optimized inventory management. Joint adoption by all PSC stakeholders is crucial to maximize these benefits, promote alignment and resilience, and ensure safe medication availability, benefiting patients and the entire supply chain ecosystem. Three technologies seem most promising in the digitalization landscape: Artificial Intelligence (AI), blockchain, and drones. AI systems are pivotal in optimizing inventory management by demand prediction, detecting fake drugs by data mining algorithms, reducing waste, and ensuring efficient logistics. Blockchain offers end-to-end visibility and traceability of drugs throughout the PSC, preventing counterfeit and non-compliant products from reaching patients. Drones can optimize drug flow management, and improve operations transparency, particularly in emergency response. Nevertheless, the PSC still lags with missing exploitation opportunities at the overall supply chain level. Barriers encountered by PSC participants include a lack of resources and digital literacy, inefficient collaboration and information sharing, and resistance to change. Moreover, despite the potential of DTs to enhance security and data management, concerns remain about data privacy and their compliance with standards and regulatory requirements. The risk associated with extensive data sharing and integration among stakeholders may impede organizations from embracing digital innovation
A survey on the role of pharmaceutical supply chain actors in digital innovation
No full textThe pharmaceutical supply chain is crucial for ensuring timely access to medications and patient care. To address challenges and improve efficiency, organizations are increasingly investing in digital technologies such as blockchain, drones, and artificial intelligence. However, the integration of these technologies faces challenges, particularly related to resource scarcity for digitalization, cultural resistance within organizations, skill gaps, and data security concerns. Collaborative approaches among pharmaceutical supply chain partners can help overcome these challenges and accelerate digital transformation. Despite the strategic importance, research has primarily focused on understanding relationship dynamics rather than collaborative initiatives among pharmaceutical supply chain partners to enhance digital technology adoption. An exploratory survey was conducted in this study to provide insights into the specific contributions of four key pharmaceutical supply chain actors in the adoption of artificial intelligence, drones, and blockchain. The findings indicate technology providers play a central role in facilitating digital technology adoption. Key supportive initiatives are data and information exchange, implementation of a common data exchange platform, pilot tests, synergies with complementary technologies, and identification of trusted technology providers. Overall, results highlight the importance of understanding barriers and supportive actions across the PSC and offer practical guidance for managers navigating the digitalization process, emphasizing the adoption of impactful yet challenging technologies, i.e. artificial intelligence, blockchain, and drones
An investigation on digital technology adoption and supporting actors in the pharmaceutical supply chain
No full textThis research investigates the adoption of Artificial Intelligence (AI), blockchain, and drones in the Pharmaceutical Supply Chain (PSC), focusing on the driving role of Goods Suppliers (GSs), Service Providers (SPs), Technology Providers (TPs), and customers. A mixed-methods approach was employed, including a survey of 74 professionals and 12 semi-structured interviews. The results show higher adoption of AI (36% of respondents) compared to drones (18%) and blockchain (12%). Key AI applications include managing shipment deviations, selecting isothermal packaging, and reverse logistics. Blockchain is mainly used for counterfeiting prevention, supply chain redistribution, and data security, while drones are utilized for delivering to hard-to-reach areas and small parcel deliveries. TPs play a central role in driving digital technology (DT) adoption, particularly by creating synergies with providers of complementary products and services. AI adoption is also customer-driven, as pharmaceutical companies demand proof of packaging solutions, prompting packaging providers to use AI. SPs act as intermediaries between packaging providers and pharmaceutical companies. Additionally, multi-stakeholder organizations are crucial in fostering DT adoption by aligning priorities between regulatory decision-makers and PSC companies and facilitating the transition of DT from a technological concept to a practical application. While AI’s full potential—particularly in generative AI and decision-making—remains underexplored, blockchain faces challenges due to decentralized governance, and drone adoption is expected to grow with evolving regulations. Overall, the findings contribute to understanding the current landscape of DT adoption in the PSC and provide insights into overcoming barriers to accelerate the integration and standardization of AI, blockchain, and drones
A survey on the role of pharmaceutical supply chain actors in digital innovation
No full textThe pharmaceutical supply chain is crucial for ensuring timely access to medications and patient care. To address challenges and improve efficiency, organizations are increasingly investing in digital technologies such as blockchain, drones, and artificial intelligence. However, the integration of these technologies faces challenges, particularly related to resource scarcity for digitalization, cultural resistance within organizations, skill gaps, and data security concerns. Collaborative approaches among pharmaceutical supply chain partners can help overcome these challenges and accelerate digital transformation. Despite the strategic importance of digital technology adoption, research has primarily focused on understanding relationship dynamics rather than collaborative initiatives among pharmaceutical supply chain partners to enhance digital technology adoption. An exploratory survey was conducted in this study to assess the degree of digital innovation adoption within pharmaceutical supply chain operations and provide insights into the specific contributions of four key pharmaceutical supply chain actors in the adoption of artificial intelligence, drones, and blockchain. The findings indicate a greater adoption of artificial intelligence compared to drones and blockchain. Technology providers play a central role in facilitating digital technology adoption. This study identifies key supportive initiatives such as unified data exchange platforms, pilot tests, synergies with complementary technologies, and identification of trusted technology providers. The regression analysis suggests a positive correlation between the adoption of artificial intelligence, blockchain, and drones, with research centers emerging as key supporting actors of technological advancement within the pharmaceutical supply chain. Overall, results highlight the importance of understanding barriers and supportive actions across the PSC and offer practical guidance for managers navigating the digitalization process, emphasizing the adoption of impactful yet challenging technologies, i.e. artificial intelligence, blockchain, and drones
Technology adoption in pharmaceutical supply chain: A systematic literature review
No full textThe Pharmaceutical Supply Chain (PSC) is a complex and sensitive chain that requires to be managed effectively given its direct effects on public health and people’s lives. Introducing digital solutions within the key supply chain process and decision areas can certainly help make them more transparent, traceable and well-coordinated, as well as improve knowledge management among all participants in the PSC. However, the path to digital transformation still presents some challenges in terms of technology acceptance by organisations. In this paper we present a Systematic Literature Review (SLR) of the existing studies on the main acceptance models in the PSC and, in general, on the determinants of Digital Technology (DT) adoption by organisations. The resulting 94 articles were classified according to three dimensions: the DTs analysed, the key processes of the supply chain in which they were implemented, and the addressed acceptance and adoption factors. Despite the disparate benefits of the emerging DTs, the results show that there are still many barriers to their introduction into healthcare and specifically within the PSC. The most important ones turn out to be those relating to the compatibility of technology with existing systems, both from an organisational and technological point of view
To be or not to be... digital! How supply chain partners can support the adoption of digital technologies
No full textThis research examines the adoption of Artificial Intelligence, blockchain, and drones in the pharmaceutical supply chain, with a focus on the role of collaboration among supply chain partners. Using a mixed-methods approach, the findings indicate a higher adoption rate of AI compared to blockchain and drones. Technology providers are leading the way in supporting organizations on their digital transformation journey, often through partnerships with complementary service providers. The study also underscores the importance of multi-stakeholder collaboration in overcoming barriers to digital technology integration and standardization within the PSC
An investigation on Artificial Intelligence adoption in the pharmaceutical supply chain
No full textEffective management of the Pharma Supply Chain (PSC) is essential for the timely distribution of medications, directly influencing patient care and treatment outcomes. Following global disruptions like the recent epidemiological emergency, pharmaceutical organizations are investing in digital technologies (DT) to accelerate drug discovery, optimize research operations, and maintain the integrity of drug distribution. Among the emerging DTs, Artificial Intelligence (AI) stands out for its potential to transform the PSC, enhancing various critical processes from sourcing to consumption [1]. However, the widespread adoption of AI in the PSC faces barriers, including limited investment, data privacy concerns, regulatory hurdles, and the need for specialized expertise [2]. Collaboration among supply chain partners can be crucial to overcoming these barriers and mitigating risks associated with DT adoption [3]. Successful AI integration also depends on the technological readiness of all stakeholders. To address gaps in digital skills and experience, supporting actions and incentives are necessary to build the capacity of managers and employees at the overall supply chain level [4].
This work aims to explore the level of AI adoption within the PSC, also in synergy with other key DTs such as blockchain and drones, and the role of four key partners – goods suppliers (GSs), service providers (SPs), technology providers (TPs), and customers – in driving this proces
La crise des réseaux d'infrastructure : Le cas de Buenos-Aires, G. Dupuy avec la collaboration de D. Albini, T. Bodard, L. Costa, F. Lopzada , P. Parrod
No full textLa crise des réseaux d'infrastructure : Le cas de Buenos-Aires, G. Dupuy avec la collaboration de D. Albini, T. Bodard, L. Costa, F. Lopzada , P. Parrod. In: NETCOM : Réseaux, communication et territoires / Networks and Communication Studies, vol. 1 n°3, septembre 1987. p. 581
La crise des réseaux d'infrastructure : Le cas de Buenos-Aires, G. Dupuy avec la collaboration de D. Albini, T. Bodard, L. Costa, F. Lopzada , P. Parrod
No full textLa crise des réseaux d'infrastructure : Le cas de Buenos-Aires, G. Dupuy avec la collaboration de D. Albini, T. Bodard, L. Costa, F. Lopzada , P. Parrod. In: NETCOM : Réseaux, communication et territoires / Networks and Communication Studies, vol. 1 n°3, septembre 1987. p. 581
G. Dupuy en collaboration avec D. Albini, T. Bodard, A. Costa, F. Lozada, P. Panod, La crise des réseaux d'infrastructure : le cas de Buenos Aires, juillet 1987
No full textDuhem Bernard. G. Dupuy en collaboration avec D. Albini, T. Bodard, A. Costa, F. Lozada, P. Panod, La crise des réseaux d'infrastructure : le cas de Buenos Aires, juillet 1987. In: Les Annales de la recherche urbaine, N°35-36, 1987. Chômages, mutations, territoires. p. 120
- …
